Dr. Eric W Baum , MD
Specialist • Gadsden, AL
101 Cherry St
Gadsden, AL 359015234
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on July 11, 2006; this date does not establish years in practice.
-
Published CMS data list 607 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 17003 — Destruction of precancer skin growth, 2-14 growths: 221 service units.
- 99213 — Established patient outpatient office visit: 128 service units.
- 17000 — Destruction of precancer skin growth, 1 growth: 103 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 8 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 574 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Triamcinolone Acetonide — 131 prescription fills, including refills.
- Clobetasol Propionate — 41 prescription fills, including refills.
- Fluocinonide — 37 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 21 records in the table · Guide: How to read Medicare Part D prescriber data
-
Fewer Medicare Part B services than 60% of clinicians listed under Specialist in Alabama (2024, 154 clinicians with data). Median for this group: 1,073. Middle half: 294 to 2,658.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 2,373 in 2020 to 607 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
101 Cherry St
Gadsden, AL 359015234
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Southeastern Dermatology Group Pa. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
State University Of New York At Stony Brook, School Of Medicine
1978
What Public CMS Data Show
Specialist: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
174 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $30,342 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $21,721 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
633 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$639,921 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $114,193.59 across 156 records.
By nature of payment
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $98,169.00 across 23 records.
- Travel and Lodging: $13,073.47 across 47 records.
- Food and Beverage: $2,951.12 across 86 records.
Reporting-company totals (3 largest of 12)
- UCB, Inc.: $59,304.76 across 67 records.
- Sanofi and Genzyme US Companies: $30,462.97 across 12 records.
- Amgen Inc.: $14,612.47 across 16 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
48 years (graduated 1978)
CMS Doctors and Clinicians data list 1978 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Baum has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Baum as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Gadsden and Alabama
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Fewer Medicare Part B services than 60% of clinicians listed under Specialist in Alabama (2024, 154 clinicians with data). Median for this group: 1,073. Middle half: 294 to 2,658.
Too few clinicians listed under Specialist in Gadsden have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A lower Medicare-allowed amount than 65% of clinicians listed under Specialist in Alabama (2024, 154 clinicians with data). Median for this group: $60,469. Middle half: $20,778 to $147,408.
Too few clinicians listed under Specialist in Gadsden have Medicare Part B data for 2024 to compare.
Paid by Medicare
A lower Medicare payment amount than 70% of clinicians listed under Specialist in Alabama (2024, 154 clinicians with data). Median for this group: $45,265. Middle half: $15,498 to $105,953.
Too few clinicians listed under Specialist in Gadsden have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
Close to the middle for clinicians listed under Specialist in Alabama (2024, 145 clinicians with data). Median for this group: 762. Middle half: 186 to 2,437.
Too few clinicians listed under Specialist in Gadsden have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 85% of clinicians listed under Specialist in Alabama (2024, 145 clinicians with data). Median for this group: $41,558. Middle half: $3,769 to $290,757.
Too few clinicians listed under Specialist in Gadsden have Medicare Part D data for 2024 to compare.
12 active clinicians are listed under Specialist with a practice address in Gadsden, AL (545 in Alabama).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Gadsden
0% of these 12 clinicians have the CMS telehealth indicator.
41.7% of these 12 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 74% from 2,373 in 2020 to 607 in 2024.
- 2020: 2,373
- 2021: 1,754
- 2022: 1,049
- 2023: 828
- 2024: 607
-
Medicare-allowed amount
Medicare-allowed amount decreased 74% from $118,954 in 2020 to $30,342 in 2024.
- 2020: $118,954
- 2021: $119,984
- 2022: $66,340
- 2023: $39,738
- 2024: $30,342
-
Paid by Medicare
Paid by Medicare decreased 74% from $84,342 in 2020 to $21,721 in 2024.
- 2020: $84,342
- 2021: $85,760
- 2022: $45,963
- 2023: $29,594
- 2024: $21,721
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 68% from 1,778 in 2020 to 574 in 2024.
- 2020: 1,778
- 2021: 1,251
- 2022: 813
- 2023: 519
- 2024: 574
-
30-day fills
30-day fills decreased 68% from 1,966 in 2020 to 633 in 2024.
- 2020: 1,966
- 2021: 1,378
- 2022: 909
- 2023: 624
- 2024: 633
-
Part D drug cost
Part D drug cost decreased 50% from $1,288,355 in 2020 to $639,921 in 2024.
- 2020: $1,288,355
- 2021: $1,222,728
- 2022: $1,210,587
- 2023: $1,149,361
- 2024: $639,921
-
Industry payments (Open Payments)
Industry payments (Open Payments) varied from year to year: $110,984.83 in 2021 and $114,193.59 in 2025.
- 2021: $110,984.83
- 2022: $118,991.30
- 2023: $70,741.57
- 2024: $213,326.42
- 2025: $114,193.59
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 156 records totaling $114,193.59.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Sanofi and Genzyme US Companies |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $7,259.00 |
| Sanofi and Genzyme US Companies |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $7,259.00 |
| Sanofi and Genzyme US Companies |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $7,259.00 |
| Sanofi and Genzyme US Companies |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $7,259.00 |
| Regeneron Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $6,619.00 |
| UCB, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Bimzelx | General | $6,500.00 |
| UCB, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Bimzelx | General | $5,796.00 |
| UCB, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Bimzelx | General | $5,000.00 |
| UCB, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Bimzelx | General | $5,000.00 |
| UCB, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Bimzelx | General | $5,000.00 |
| UCB, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Bimzelx | General | $5,000.00 |
| UCB, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Bimzelx | General | $5,000.00 |
| UCB, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Bimzelx | General | $5,000.00 |
| Amgen Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
OTEZLA | General | $3,900.00 |
| Amgen Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
OTEZLA | General | $3,900.00 |
| Amgen Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
OTEZLA | General | $3,250.00 |
| UCB, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Bimzelx | General | $1,725.00 |
| UCB, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Bimzelx | General | $1,725.00 |
| UCB, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Bimzelx | General | $1,725.00 |
| Amgen Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
— | General | $1,625.00 |
| UCB, Inc. |
Travel and Lodging
In-kind items and services
|
Bimzelx | General | $1,401.48 |
| UCB, Inc. |
Travel and Lodging
In-kind items and services
|
Bimzelx | General | $1,139.37 |
| Regeneron Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DUPIXENT | General | $1,068.00 |
| UCB, Inc. |
Travel and Lodging
In-kind items and services
|
Bimzelx | General | $1,007.91 |
| UCB, Inc. |
Travel and Lodging
In-kind items and services
|
Bimzelx | General | $1,000.89 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
17003
Destruction of precancer skin growth, 2-14 growths
|
221 | 48 | $12.71 | $6.20 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
128 | 94 | $177.00 | $87.12 |
|
17000
Destruction of precancer skin growth, 1 growth
|
103 | 68 | $130.00 | $58.16 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
83 | 61 | $109.00 | $53.53 |
|
17110
Destruction of skin growth, 1-14 growths
|
22 | 21 | $216.00 | $100.60 |
|
11102
Biopsy of related skin growth, first growth
|
21 | 20 | $191.00 | $89.34 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
18 | 18 | $249.00 | $118.87 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
11 | 11 | $218.00 | $105.26 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Triamcinolone Acetonide | Triamcinolone Acetonide | 131 | 4,082 | $2,105.38 | 74 |
| Clobetasol Propionate | Clobetasol Propionate | 41 | 1,169 | $2,819.11 | 17 |
| Fluocinonide | Fluocinonide | 37 | 1,005 | $1,550.17 | 19 |
| Enbrel | Etanercept | 37 | 1,064 | $272,976.47 | — |
| Ciclopirox | Ciclopirox Olamine | 34 | 1,095 | $998.15 | 16 |
| Doxycycline Hyclate | Doxycycline Hyclate | 31 | 843 | $552.15 | — |
| Cosentyx Sensoready (2 Pens) | Secukinumab | 31 | 868 | $223,897.57 | — |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 29 | 777 | $225.40 | 12 |
| Fluconazole | Fluconazole | 28 | 831 | $745.55 | — |
| Hydrocortisone | Hydrocortisone | 19 | 349 | $101.46 | 17 |
| Methotrexate | Methotrexate Sodium | 19 | 1,154 | $377.93 | — |
| Mupirocin | Mupirocin | 18 | 439 | $113.37 | 13 |
| Alclometasone Dipropionate | Alclometasone Dipropionate | 16 | 500 | $840.67 | — |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 15 | 320 | $640.30 | — |
| Ciclopirox | Ciclopirox | 15 | 450 | $664.88 | — |
| Fluticasone Propionate | Fluticasone Propionate | 14 | 412 | $330.68 | — |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 13 | 364 | $638.26 | — |
| Terbinafine Hcl | Terbinafine Hcl | 13 | 522 | $89.88 | — |
| Metronidazole | Metronidazole | 11 | 330 | $1,137.20 | — |
| Valacyclovir | Valacyclovir Hcl | 11 | 640 | $465.39 | — |
| Humira(Cf) Pen | Adalimumab | 11 | 308 | $128,650.59 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 174400000X
An individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - DERMATOLOGY
I20101117000929
AL
3971672445
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Southeastern Dermatology Group Pa
106 Westside Dr, Dothan, AL 363030106
Phone: 3346993376
Southeastern Dermatology Group Pa
101 Cherry St, Gadsden, AL 359015234
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner - Adult Health
Certified Registered Nurse Practitioner
Career & Practice History
NPI enumerated July 11, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Specialists in Gadsden
- Dr. Bryan Grissett, MD
- Dr. Anthony Catanzaro, MD
- Dr. Henry Ruiz, MD
- Dr. Wan Kwan, MD
- Dr. Terisa Thomas, MD
- Dr. Charles Dabbs, MD
Mailing Address
101 Cherry St
Gadsden, AL 359015234
Phone: 2565432380